Profitelligence Profitelligence · Filing Ledger Open SYK research →

Form 8-K · Current Report · Filed 2026-06-26

Stryker Corporation Announces Organizational Restructuring and Segment Recast

Stryker Corporation has announced a reorganization of its business segments, combining its orthopaedic instruments portfolio with the Mako and enabling technologies portfolio to form a new Ortho Tech business.

Filer
Stryker Corporation SYK · NYSE
Filed
Accession
0000310764-26-000041
CIK
0000310764
Signal
Medium impactHealthcare

Details

This restructuring aims to simplify the customer experience and accelerate innovation. As a result, the company will continue to report two business segments: MedSurg and Neurotechnology, and Orthopaedics. The filing includes a recast of the prior period financial statements to reflect these segment changes, as required by SEC rules. This filing does not amend or restate the previously issued financial statements but provides updated segment information in conjunction with the change in business structure.

Items reported

Item events

Reported Item

Restructuring Costs Corporate Update

Market reaction

Close before filing

$316.11

Next session

+4.6%

Since filing

+3.0%

Latest close

$325.70

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from SYK reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, SYK insiders reported 13 Form 4 transactions — net selling of $98.2M.

Full SYK insider history →

About Stryker Corporation

Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.

Exchange NYSE Industry Medical Devices Company website ↗

Never miss another SYK filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts